ARCHIVES

FDA Approves Abbott’s HER-2 DNA Probe Kit.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

Shorter Hospital Stay After Robot-Assisted Surgeries

February 27, 2009

Radiation Improves Survival In Advanced Prostate Cancer

June 25, 2010

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

Complete List of Recommendations by Centers Committee

October 18, 1996

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013